Hif-1α/Slit2 Mediates Vascular Smooth Muscle Cell Phenotypic Changes in Restenosis of Bypass Grafts

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2023 Apr 25

PMID 37097589

Authors

Sen Li

Zhiwei Gao

Haiqing Li

Chang Xu

Bing Chen

Qing Zha

Ke Yang

Weilin Wang

Affiliations

Soon will be listed here.

Abstract

Vascular smooth muscle cells (VSMCs) are involved in restenosis of bypass grafts and cause artery graft occlusion. This study aimed to explore the role of Slit2 in phenotypic switching of VSMCs and its effect on restenosis of vascular conduits. An animal model of vascular graft restenosis (VGR) was produced in SD rats and assessed by echocardiography. The expression of Slit2 and Hif-1α was measured in vivo and in vitro. After Slit2 overexpression, the migration and proliferation of VSMCs were detected in vitro, and the restenosis rates and phenotype of VSMCs were tested in vivo. The arteries of the VGR model presented significant stenosis, and Slit2 was decreased in VSMCs of the VGR model. In vitro, Slit2 overexpression inhibited the migration and proliferation of VSMCs, but Slit2 knockdown promoted migration and proliferation. Hypoxia induced Hif-1α but reduced Slit2, and Hif-1α negatively regulated Slit2 expression. Moreover, Slit2 overexpression weakened the rate of VGR and maintained the patency of artery bypass grafts, which suppressed the phenotypic switching of VSMCs. Slit2 inhibited the synthetic phenotype transformation to inhibit the migration and proliferation of VSMCs and delayed the VGR via Hif-1α.

Citing Articles

The chemorepellent, SLIT2, bolsters innate immunity against .

Bhosle V, Sun C, Patel S, Ho T, Westman J, Ammendolia D Elife. 2023; 12.

PMID: 37773612 PMC: 10541174. DOI: 10.7554/eLife.87392.

References

Sarjeant J, Rabinovitch M . Understanding and treating vein graft atherosclerosis. Cardiovasc Pathol. 2002; 11(5):263-71. DOI: 10.1016/s1054-8807(02)00125-4. View

Mayor R, Etienne-Manneville S . The front and rear of collective cell migration. Nat Rev Mol Cell Biol. 2016; 17(2):97-109. DOI: 10.1038/nrm.2015.14. View

Yang K, Zhang X, Cao L, Liu X, Liu Z, Wang X . Toll-like receptor 4 mediates inflammatory cytokine secretion in smooth muscle cells induced by oxidized low-density lipoprotein. PLoS One. 2014; 9(4):e95935. PMC: 3995878. DOI: 10.1371/journal.pone.0095935. View

Harskamp R, Lopes R, Baisden C, de Winter R, Alexander J . Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013; 257(5):824-33. DOI: 10.1097/SLA.0b013e318288c38d. View

Khaleel M, Dorheim T, Duryee M, Durbin Jr H, Bussey W, Garvin R . High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Ann Thorac Surg. 2011; 93(2):552-8. DOI: 10.1016/j.athoracsur.2011.10.035. View

Choudhary B, Antoniades C, Brading A, Galione A, Channon K, Taggart D . Diabetes mellitus as a predictor for radial artery vasoreactivity in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2007; 50(11):1047-53. DOI: 10.1016/j.jacc.2007.06.008. View

Shi R, Qu N, Liao T, Wang Y, Wang Y, Sun G . Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer. Int J Oncol. 2016; 48(5):2055-62. DOI: 10.3892/ijo.2016.3412. View

Chanakira A, Kir D, Barke R, Santilli S, Ramakrishnan S, Roy S . Hypoxia Differentially Regulates Arterial and Venous Smooth Muscle Cell Migration. PLoS One. 2015; 10(9):e0138587. PMC: 4575051. DOI: 10.1371/journal.pone.0138587. View

Campbell G, Campbell J . Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol. 1985; 42(2):139-62. DOI: 10.1016/0014-4800(85)90023-1. View

10.

Ypsilanti A, Zagar Y, Chedotal A . Moving away from the midline: new developments for Slit and Robo. Development. 2010; 137(12):1939-52. DOI: 10.1242/dev.044511. View

11.

Zhang N, Yang L, Meng L, Cui H . Inhibition of miR-200b-3p alleviates hypoxia-ischemic brain damage via targeting Slit2 in neonatal rats. Biochem Biophys Res Commun. 2020; 523(4):931-938. DOI: 10.1016/j.bbrc.2020.01.029. View

12.

Wan J, Lata C, Santilli A, Green D, Roy S, Santilli S . Supplemental oxygen reverses hypoxia-induced smooth muscle cell proliferation by modulating HIF-alpha and VEGF levels in a rabbit arteriovenous fistula model. Ann Vasc Surg. 2013; 28(3):725-36. PMC: 3968233. DOI: 10.1016/j.avsg.2013.10.007. View

13.

Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, Di Giammarco G . Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Circulation. 2017; 136(18):1749-1764. DOI: 10.1161/CIRCULATIONAHA.117.027597. View

14.

Ross R . The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986; 314(8):488-500. DOI: 10.1056/NEJM198602203140806. View

15.

Gaspardone A, Versaci F . Coronary stenting and inflammation. Am J Cardiol. 2006; 96(12A):65L-70L. DOI: 10.1016/j.amjcard.2005.09.064. View

16.

Chaturvedi S, Robinson L . Slit2-Robo signaling in inflammation and kidney injury. Pediatr Nephrol. 2014; 30(4):561-6. DOI: 10.1007/s00467-014-2825-4. View

17.

Allahverdian S, Chaabane C, Boukais K, Francis G, Bochaton-Piallat M . Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 2018; 114(4):540-550. PMC: 5852505. DOI: 10.1093/cvr/cvy022. View

18.

Antoniades C, Shirodaria C, Crabtree M, Rinze R, Alp N, Cunnington C . Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation. 2007; 116(24):2851-9. DOI: 10.1161/CIRCULATIONAHA.107.704155. View

19.

Levy N . The use of animal as models: ethical considerations. Int J Stroke. 2012; 7(5):440-2. DOI: 10.1111/j.1747-4949.2012.00772.x. View

20.

Shi N, Chen S . Mechanisms simultaneously regulate smooth muscle proliferation and differentiation. J Biomed Res. 2014; 28(1):40-6. PMC: 3904173. DOI: 10.7555/JBR.28.20130130. View